Strategic Account Manager -Strategic Account Manager - Federal Govern…
PROCEPT BioRobotics- Full Time
- Junior (1 to 2 years)
A Cardiovascular Account Specialist will introduce Cytokinetics in their dedicated territory and launch its first commercial product, a novel cardiac myosin inhibitor for Hypertrophic Cardiomyopathy (HCM). This role focuses on driving performance through strategic relationships with IDNs, hospitals, cardiology clinics, and specialty pharmacies, establishing the company as a key resource for patients with HCM.
Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. The company’s core values include:
Develops drugs for muscle function disorders
Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.